These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. In utero congestive heart failure due to maternal indomethacin treatment for polyhydramnios and premature labour in a fetus with antenatal closure of the foramen ovale. Achiron R; Lipitz S; Kidron D; Berant M; Hegesh J; Rotstein Z Prenat Diagn; 1996 Jul; 16(7):652-6. PubMed ID: 8843476 [TBL] [Abstract][Full Text] [Related]
29. The safety of prolonged indomethacin therapy. Savage AH; Anderson BL; Simhan HN Am J Perinatol; 2007 Apr; 24(4):207-13. PubMed ID: 17447185 [TBL] [Abstract][Full Text] [Related]
30. Acute renal failure in the neonate induced by the administration of indomethacin as a tocolytic agent. Pomeranz A; Korzets Z; Dolfin Z; Eliakim A; Bernheim J; Wolach B Nephrol Dial Transplant; 1996 Jun; 11(6):1139-41. PubMed ID: 8671983 [No Abstract] [Full Text] [Related]
31. Recent indomethacin tocolysis is not associated with neonatal complications in preterm infants. Vermillion ST; Newman RB Am J Obstet Gynecol; 1999 Nov; 181(5 Pt 1):1083-6. PubMed ID: 10561622 [TBL] [Abstract][Full Text] [Related]
32. Renal impairment in very low birthweight infants following antenatal indomethacin administration. Nishikubo T; Takahashi Y; Nakagawa Y; Kawaguchi C; Nakajima M; Ichijo M; Yoshioka A Acta Paediatr Jpn; 1994 Apr; 36(2):202-6. PubMed ID: 8203268 [TBL] [Abstract][Full Text] [Related]
33. Effects of indomethacin on the fetus. Ovadia M N Engl J Med; 1988 Dec; 319(22):1484-5. PubMed ID: 3185670 [No Abstract] [Full Text] [Related]
34. Risk of persistent renal insufficiency in premature infants following the prenatal use of indomethacin for suppression of preterm labor. Butler-O'Hara M; D'Angio CT J Perinatol; 2002; 22(7):541-6. PubMed ID: 12368969 [TBL] [Abstract][Full Text] [Related]
35. Randomized comparative trial of indomethacin and ritodrine for the long-term treatment of preterm labor. Besinger RE; Niebyl JR; Keyes WG; Johnson TR Am J Obstet Gynecol; 1991 Apr; 164(4):981-6; discussion 986-8. PubMed ID: 2014850 [TBL] [Abstract][Full Text] [Related]
36. Premature onset of labor, neonatal patent ductus arteriosus, and prostaglandin synthetase antagonists--a rat model of a human problem. Altshuler G; Krous HF; Altmiller DH; Sharpe GL Am J Obstet Gynecol; 1979 Sep; 135(2):261-5. PubMed ID: 112867 [TBL] [Abstract][Full Text] [Related]
37. [Fetal advantages and benefits of the treatment of threatened premature labor by beta mimetics]. Bourgeois J Rev Fr Gynecol Obstet; 1992; 87(7-9):391-2. PubMed ID: 1359628 [No Abstract] [Full Text] [Related]
38. [Use of salbutamol in the treatment of threatened premature labor: tocolytic, cardiotocographic, electrocardiographic, phonomechanographic study. Preliminary results and experience]. Allegra SP; Balacco F; Rossi A Ann Ostet Ginecol Med Perinat; 1977; 98(1):12-27. PubMed ID: 848818 [No Abstract] [Full Text] [Related]
39. [Evaluation of newborn infants' condition when delivered from women receiving oral dexamethasone in cases of threatened premature labor]. Woytoń J; Gajewska E; Szacki J; Bartoszewicz T Ginekol Pol; 1978 Jan; 49(1):35-8. PubMed ID: 640480 [No Abstract] [Full Text] [Related]
40. The effects of indomethacin and a beta-sympathomimetic agent on the fetal ductus arteriosus during treatment of premature labor: a randomized double-blind study. Eronen M; Pesonen E; Kurki T; Ylikorkala O; Hallman M Am J Obstet Gynecol; 1991 Jan; 164(1 Pt 1):141-6. PubMed ID: 1986601 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]